BRAFV600E-mutated central nervous system tumors benefit from treatment with dabrafenib plus trametinib: Results from the Drug Rediscovery Protocol

Authors:
Open Access
Publisher website
Google Scholar
Abstract
No abstract available
Funding Information
  • HORIZON EUROPE Framework Programme (101104269)
  • European Health and Digital Executive Agency (101079984)
  • KWF Kankerbestrijding (14809)
  • KWF Kankerbestrijding (10014)
  • Oncode Institute

This publication has 38 references indexed in Scilit: